Filed: 11/8/2022ACC: 0001910264-22-000004
📋 What this filing means
SR ONE CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $218.7K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$218.7K
Total AUM (reported)
19.28M
Total Shares
Allocation by class
COM$115.5K52.8%
COMMON STOCK$103.2K47.2%
Portfolio Concentration
Top 3$214.9K98.2%
4–10$3.9K1.8%
Top 3 weight
98.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 19.28M
Sole
Full voting authority
19.28M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
ARCELLX INC.
SOLEShares5.50M
TypeSH
Market value$103.2K
47.19%
Sole
5.50M
Shared
0.00
None
0.00
DESIGN THERAPEUTICS INC
SOLEShares5.63M
TypeSH
Market value$94.1K
43.01%
Sole
5.63M
Shared
0.00
None
0.00
NKARTA INC.
SOLEShares1.33M
TypeSH
Market value$17.5K
8.02%
Sole
1.33M
Shared
0.00
None
0.00
EFFECTOR THERAPEUTICS INC
SOLEShares6.82M
TypeSH
Market value$3.9K
1.78%
Sole
6.82M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARCELLX INC.SOLE | COMMON STOCK | 5.50M | SH | $103.2K 47.19% | 5.50M | 0.00 | 0.00 |
DESIGN THERAPEUTICS INCSOLE | COM | 5.63M | SH | $94.1K 43.01% | 5.63M | 0.00 | 0.00 |
NKARTA INC.SOLE | COM | 1.33M | SH | $17.5K 8.02% | 1.33M | 0.00 | 0.00 |
EFFECTOR THERAPEUTICS INCSOLE | COM | 6.82M | SH | $3.9K 1.78% | 6.82M | 0.00 | 0.00 |